Patni Rajiv
SEC insider (Form 3/4/5 filer). CIK 0001616200. Chief Medical Officer at Septerna, Inc. (SEPN) and 2 other issuers. 4 reported Form 4/5 transactions since Sep 2024; latest on Sep 8, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Patni Rajiv has filed insider reports for
- Septerna, Inc. (SEPN): Officer, Chief Medical Officer
- BioXcel Therapeutics, Inc. (BTAI): Director
- Quince Therapeutics, Inc. (QNCX): Director
Patni Rajiv
CIK: 0001616200
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Sep 8, 2026SEPN
Septerna, Inc.
AwardDirectStock Option (Right to Buy)
275K shares- - Jan 9, 2026BTAI
BioXcel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
17K shares- - Jun 4, 2025QNCX
Quince Therapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
27K shares- - Jan 15, 2025BTAI
BioXcel Therapeutics, Inc.
AwardDirectStock Option (right to buy)
44K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 8, 2026 |  SEPN Septerna, Inc. | Award Stock Option (Right to Buy) | 275,000 | - | - | Direct |
| Jan 9, 2026 |  BTAI BioXcel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 17,000 | - | - | Direct |
| Jun 4, 2025 |  QNCX Quince Therapeutics, Inc. | Award Director Stock Option (Right to Buy) | 27,000 | - | - | Direct |
| Jan 15, 2025 | BTAI BioXcel Therapeutics, Inc. | Award Stock Option (right to buy) | 44,000 | - | - | Direct |
1-4 of 4 transactions